Drug Firms, CROs Complain Of Burden Of India's Informed-Consent Rule
This article was originally published in PharmAsia News
Executive Summary
Drug makers and contract research organizations conducting clinical trials in India face a dilemma in protecting the confidentiality of participants now required to be taped receiving information on risks.